Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-058476
Filing Date
2012-12-18
Accepted
2012-12-18 19:54:20
Documents
2
Period of Report
2012-12-10

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c30774_4x1.html 4  
1 MAIN DOCUMENT DESCRIPTION c30774_4x1.xml 4 3834
2 POWER OF ATTORNEY c30774_24.htm EX-24 3415
  Complete submission text file 0001209191-12-058476.txt   8804
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address SPENCER TRASK 535 MADISON AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address
STERN ADAM K (Reporting) CIK: 0001403497 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52089 | Film No.: 121272831